Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation

Mayo Clinic Proceedings

Volumn 78, Issue 5, 2003, Pages 630-634

  Parish, James M ^a   Muhm, John R ^a   Leslie, Kevin O ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; BACTERIUM CULTURE; BONE MARROW TRANSPLANTATION; BREAST CANCER; BRONCHOSCOPY; CASE REPORT; CHRONIC DRUG ADMINISTRATION; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; DRUG MEGADOSE; FEMALE; GLIOMA; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG TOXICITY; PHYSICAL EXAMINATION; PNEUMOCONIOSIS; PNEUMOTHORAX; RESPIRATORY TRACT INFECTION; SARCOIDOSIS; SILICOSIS; THORAX RADIOGRAPHY;

EID: 0038407503     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.5.630     Document Type: Article

References (16)

1. O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattameneni HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med. 1990;323:378-382.
2. Patz EF Jr, Peters WP, Goodman PC. Pulmonary drug toxicity following high-dose chemotherapy with autologous bone marrow transplantation: CT findings in 20 cases. J Thorac. Imaging. 1994;9:129-134.
3. Padley SP, Adler B, Hansell DM, Muller NL. High-resolution computed tomography of drug-induced lung disease. Clin Radiol. 1992;46:232-236.
4. Durant JR, Norgard MJ, Murad TM, Bartolucci AA, Langford KH. Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU). Ann Intern Med. 1979;90:191-194.
5. Weiss RB, Poster DS, Penta JS. The nitrosoureas and pulmonary toxicity. Cancer Treat Rev. 1981;8:111-125.
6. Holoye PY, Jenkins DE, Greenberg SD. Pulmonary toxicity in long-term administration of BCNU. Cancer Treat Rep. 1976;60:1691-1694.
7. Selker RG, Jacobs SA, Moore PB, et al. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis. Neurosurgery. 1980;7:560-565.
8. Weinstein AS, Diener-West M, Nelson DF, Pakuris E. Pulmonary toxicity of carmustine in patients treated for malignant glioma. Cancer Treat Rep. 1986;70:943-946.
9. Seiden MV, Elias A, Ayash L, et al. Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens. Bone Marrow Transplant. 1992;10:57-63.
10. Ager S, Mahendra P, Richards EM, Bass G, Baglin TP, Marcus RE. High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity study. Bone Marrow Transplant. 1996;17:335-340.
11. Rubio C, Hill ME, Milan S, O'Brien ME, Cunningham D. Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease. Br J Cancer. 1997;75:1044-1048.
12. Kalaycioglu M, Kavuru M, Tuason L, Bolwell B. Empiric prednisone therapy for pulmonary toxic reaction after high-dose chemotherapy containing carmustine (BCNU). Chest. 1995;107:482-487.
13. Wilczynski SW, Erasmus JJ, Petros WP, Vredenburgh JJ, Folz RJ. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med. 1998;157:565-573.
14. Todd NW, Peters WP, Ost AH, Roggli VL, Piantadosi CA. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation. Am Rev Respir Dis. 1993;147:1264-1270.
15. Taylor PM, O'Driscoll BR, Gattamaneni HR, Woodcock AA. Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features. Clin Radiol. 1991;44:299-301.
16. Hasleton PS, O'Driscoll BR, Lynch P, et al. Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma. J Pathol. 1991;164:31-36.